NeoGenomics makes oncology test portfolio available through Epic Aura (ir.neogenomics.com)

• Full oncology test ordering through Epic Aura
• Expected 20-30% adoption increase per site
• Future support for liquid biopsy and MRD

"NeoGenomics, a US oncology diagnostics provider, integrated its full test portfolio into Epic Aura, enabling physicians to order tests and view results within the Epic EHR workflow. The move aims to lower barriers to precision oncology adoption and accelerate time to treatment. CEO Tony Zook highlighted improved accessibility. The integration is expected to drive a 20-30% increase in test adoption per site."